Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0051 | 0.1287 | 1 |
Mycobacterium tuberculosis | Probable ATP synthase a chain AtpB (protein 6) | 0.0246 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.814 | 1 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.2551 | 1 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0046 | 0.1048 | 0.1288 |
Wolbachia endosymbiont of Brugia malayi | ATP synthase F0F1 subunit A | 0.0246 | 1 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.0175 | 0.6815 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0051 | 0.1287 | 1 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.008 | 0.2551 | 0.3134 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0051 | 0.1287 | 1 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.008 | 0.2551 | 0.3742 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0051 | 0.1287 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0175 | 0.6815 | 0.8373 |
Schistosoma mansoni | ATP synthase F0 subunit 6 | 0.0246 | 1 | 1 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0175 | 0.6815 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.017 | 0.6596 | 0.8103 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0047 | 0.1095 | 0.4293 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.008 | 0.2551 | 1 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.008 | 0.2551 | 0.3742 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0175 | 0.6815 | 0.6815 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0051 | 0.1287 | 0.1581 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0051 | 0.1287 | 1 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.008 | 0.2551 | 0.3134 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.814 | 0.814 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0047 | 0.1095 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.2551 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.814 | 0.814 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0047 | 0.1095 | 1 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.008 | 0.2551 | 1 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0046 | 0.1048 | 0.1288 |
Echinococcus granulosus | geminin | 0.0205 | 0.814 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.008 | 0.2551 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0 | 0.5 |
Mycobacterium ulcerans | F0F1 ATP synthase subunit A | 0.0246 | 1 | 1 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.008 | 0.2551 | 0.2551 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.